Diabetic Nephropathy
Antihypertensive Drugs: Potassium-Sparing Diuretics
Glomerular Filtration Rate and its Regulation
Chronic Kidney Disease III: Interprofessional Care
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
GPCR Desensitization
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: May 3, 2026

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
Yoichi Miyazaki1, Akihiro Shimizu, Ira Pastan
1Division of Kidney and Hypertension, Department of Internal Medicine, Jikei University School of Medicine, Tokyo, Japan.
Inhibition of Kelch-like ECH-associated protein 1 (Keap1) activates NFE2-related factor 2 (Nrf2), protecting against glomerulosclerosis in podocyte injury models. This suggests the Nrf2-Keap1 system is a viable therapeutic target for chronic kidney diseases.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: